Piramal Life Sciences, a research and development arm of Piramal Group, today posted a decline in net loss by 30.14 per cent to Rs 25.68 crore in the quarter ended December 31, 2010 over the same period last fiscal.
The company had a net loss of Rs 36.76 crore in the quarter ended December 31, 2009, Piramal Life Sciences said in a filing to the Bombay Stock Exchange.
During the quarter under review, the company’s net sales registered an over 11-fold jump in its net sales to Rs 13.98 crore from Rs 1.22 crore posted in the year-ago period.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.